| Active ingredient (INN) | Haloperidol Decanoate |
|---|---|
| Therapeutic category |
|---|
| Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| Controlled substance | No |
|---|
| Marketing-authorisation holders | HIKMA PHARMACEUTICALS USA INC., Patriot Pharmaceuticals LLC, Sagent Pharmaceuticals |
|---|
| Registrations on file | 3 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Haloperidol Decanoate | 100mg/mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Haloperidol Decanoate | 50mg/mL | injection | 🇺🇸 US | Patriot Pharmaceuticals LLC | Active |
| haloperidol decanoate | 500mg/5mL | injection | 🇺🇸 US | Sagent Pharmaceuticals | Active |